Literature DB >> 18524486

Prolonged nociceptive responses to hind paw formalin injection in rats with a spinal cord injury.

Jeung Woon Lee1, Orion Furmanski, Daniel A Castellanos, Linda A Daniels, Aldric T Hama, Jacqueline Sagen.   

Abstract

Unilateral lesioning of the spinal dorsal horn with the excitotoxin quisqualic acid (QUIS) leads to robust degeneration of dorsal horn grey matter, and robust pain-related symptoms, such as cutaneous hypersensitivity, persist long after injury. A possible mechanism that underlies the pain-related symptoms is the disruption of dorsal horn inhibitory neuron function, leading to decreased inhibition of nociceptive neurons. Five percent formalin was injected into the hind paw of rats with either a QUIS lesion or sham lesion. Both QUIS- and sham-lesioned rats displayed bi-phasic hind paw flinches following formalin injection, but a prolonged response was observed in QUIS-lesioned rats. The expression of the immediate-early gene product Fos in the dorsal horn ipsilateral to formalin injection was similar between QUIS- and sham-lesioned rats. In QUIS-lesioned rats, however, there was a marked absence of dorsal horn neurons, particularly GABAergic neurons, compared to sham-lesioned rats. The prolonged nociceptive response observed with a unilateral QUIS lesion may be due to generalized changes in dorsal horn neuron function including a loss of inhibitory neuron function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524486      PMCID: PMC2680189          DOI: 10.1016/j.neulet.2008.05.030

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  27 in total

1.  Increased spinal c-Fos expression with noxious and non-noxious peripheral stimulation after severe spinal contusion.

Authors:  Y A Berrocal; D D Pearse; C M Andrade; J F Hechtman; R Puentes; M J Eaton
Journal:  Neurosci Lett       Date:  2006-12-11       Impact factor: 3.046

2.  Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection.

Authors:  D M Basso; M S Beattie; J C Bresnahan
Journal:  Exp Neurol       Date:  1996-06       Impact factor: 5.330

3.  Subarachnoid transplant of a human neuronal cell line attenuates chronic allodynia and hyperalgesia after excitotoxic spinal cord injury in the rat.

Authors:  Mary J Eaton; Stacey Quintero Wolfe; Miguel Martinez; Massiel Hernandez; Cassandra Furst; Jian Huang; Beata R Frydel; Orlando Gómez-Marín
Journal:  J Pain       Date:  2007-01       Impact factor: 5.820

4.  Expansion of formalin-evoked Fos-immunoreactivity in rats with a spinal cord injury.

Authors:  Daniel A Castellanos; Linda A Daniels; Mena P Morales; Aldric T Hama; Jacqueline Sagen
Journal:  Neurosci Res       Date:  2007-05-03       Impact factor: 3.304

5.  Intrathecally administered c-fos antisense oligodeoxynucleotide decreases formalin-induced nociceptive behavior in adult rats.

Authors:  W Y Hou; B C Shyu; T M Chen; J W Lee; J Y Shieh; W Z Sun
Journal:  Eur J Pharmacol       Date:  1997-06-18       Impact factor: 4.432

6.  ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model.

Authors:  Zhi-Ye Zhuang; Peter Gerner; Clifford J Woolf; Ru-Rong Ji
Journal:  Pain       Date:  2005-01-26       Impact factor: 6.961

7.  Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model.

Authors:  P R Yezierski; S Liu; L G Ruenes; J K Kajander; L K Brewer
Journal:  Pain       Date:  1998-03       Impact factor: 6.961

Review 8.  Pathophysiological mechanisms of central neuropathic pain after spinal cord injury.

Authors:  P K Eide
Journal:  Spinal Cord       Date:  1998-09       Impact factor: 2.772

9.  Increases in the activated forms of ERK 1/2, p38 MAPK, and CREB are correlated with the expression of at-level mechanical allodynia following spinal cord injury.

Authors:  Eric D Crown; Zaiming Ye; Kathia M Johnson; Guo-Ying Xu; David J McAdoo; Claire E Hulsebosch
Journal:  Exp Neurol       Date:  2006-02-14       Impact factor: 5.330

10.  c-fos antisense oligodeoxynucleotide increases formalin-induced nociception and regulates preprodynorphin expression.

Authors:  J C Hunter; V L Woodburn; C Durieux; E K Pettersson; J A Poat; J Hughes
Journal:  Neuroscience       Date:  1995-03       Impact factor: 3.590

View more
  6 in total

1.  Intraspinal transplantation of GABAergic neural progenitors attenuates neuropathic pain in rats: a pharmacologic and neurophysiological evaluation.

Authors:  Stanislava Jergova; Ian D Hentall; Shyam Gajavelli; Mathew S Varghese; Jacqueline Sagen
Journal:  Exp Neurol       Date:  2011-12-13       Impact factor: 5.330

Review 2.  GABA and central neuropathic pain following spinal cord injury.

Authors:  Young S Gwak; Claire E Hulsebosch
Journal:  Neuropharmacology       Date:  2011-01-07       Impact factor: 5.250

3.  Combined extrinsic and intrinsic manipulations exert complementary neuronal enrichment in embryonic rat neural precursor cultures: an in vitro and in vivo analysis.

Authors:  Orion Furmanski; Shyam Gajavelli; Jeung Woon Lee; Maria E Collado; Stanislava Jergova; Jacqueline Sagen
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

4.  Predifferentiated GABAergic neural precursor transplants for alleviation of dysesthetic central pain following excitotoxic spinal cord injury.

Authors:  Jeung Woon Lee; Stanislava Jergova; Orion Furmanski; Shyam Gajavelli; Jacqueline Sagen
Journal:  Front Physiol       Date:  2012-05-31       Impact factor: 4.566

5.  Analgesic effect of recombinant GABAergic precursors releasing ω-conotoxin MVIIA in a model of peripheral nerve injury in rats.

Authors:  Stanislava Jergova; Melissa Hernandez; Jacqueline Sagen
Journal:  Mol Pain       Date:  2022-04       Impact factor: 3.370

6.  Recombinant neural progenitor transplants in the spinal dorsal horn alleviate chronic central neuropathic pain.

Authors:  Stanislava Jergova; Shyam Gajavelli; Nirmal Pathak; Jacqueline Sagen
Journal:  Pain       Date:  2016-04       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.